Marijuana Decriminalization

Sundial: A Surprise Winner as Cannabis Legalization Hits Setback

By Ian Bezek, InvestorPlace Contributor
Fading marijuana legalization hopes have the sector seeing red. However, SNDL stock could buck the broader industry downtrend.

There’s Still a Good Chance Sundial Stock Will Reverse Split

By Thomas Niel, InvestorPlace Contributor
Unless you're looking to make a moonshot wager on pot reform, skip out on SNDL stock.

Buy Canopy Growth as Congress Works to Decriminalize Marijuana

By Bret Kenwell, InvestorPlace Contributor
If Congress can make progress toward marijuana legalization, Canopy Growth will be in prime position to benefit. Let's look at CGC stock now.

Sundial Growers: All Eyes Are on a Bill to Decriminalize Marijuana

By Stavros Georgiadis, CFA, InvestorPlace Contributor
SNDL stock has rallied 22.8% in five days. Investors should watch for any steep selloff amid major upcoming news.

7 Weed Stocks Getting High With a Little Help From Andrew Cuomo

By Muslim Farooque, InvestorPlace Contributor
These weed stocks have the most potential of gaining the most ground in the newly legalized marijuana market in New York.

Decriminalization Won’t Pass the Senate, and Cronos Will Come Back Down

By Ken Trester
This morning, I am recommending a bearish trade on Cronos Group, Inc. (NASDAQ:CRON), the vertically integrated cannabis company.